CAMP signalling inhibits p53 acetylation and apoptosis via HDAC and SIRT deacetylases

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1815-1821

  Kloster, Martine Müller ^a   Naderi, Elin Hallan ^a   Haaland, Ingvild ^b   Gjertsen, Bjørn Tore ^b   Blomhoff, Heidi Kiil ^a   Naderi, Soheil ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute lymphoblastic leukemia cells; CAMP; Cell death; Deacetylation; DNA damage; P3 acetylation

Indexed keywords

CYCLIC AMP; HISTONE DEACETYLASE; PROTEIN MDM2; PROTEIN P53; SIRTUIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEACETYLATION; DNA DAMAGE; ENZYME INHIBITION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ACETYLATION; APOPTOSIS; CELL LINE, TUMOR; CYCLIC AMP; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SIGNAL TRANSDUCTION; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875986482     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1853     Document Type: Article

References (28)

1. Dai C and Gu W: p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 16: 528-536, 2010.
2. Appella E and Anderson CW: Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772, 2001. (Pubitemid 32862957)
3. Brooks CL and Gu W: Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164-171, 2003. (Pubitemid 36332191)
4. Brooks CL and Gu W: The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2: 456-462, 2011.
5. Gu W and Roeder RG: Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606, 1997. (Pubitemid 27357952)
6. Li M, Luo J, Brooks CL and Gu W: Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611, 2002. (Pubitemid 36042220)
7. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL: p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209, 1999. (Pubitemid 29046862)
8. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW and Appella E: DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841, 1998. (Pubitemid 28440142)
9. Wang YH, Tsay YG, Tan BC, Lo WY and Lee SC: Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem 278: 25568-25576, 2003. (Pubitemid 36835309)
10. Tang Y, Zhao W, Chen Y, Zhao Y and Gu W: Acetylation is indispensable for p53 activation. Cell 133: 612-626, 2008. (Pubitemid 351636297)
11. Torgersen KM, Vang T, Abrahamsen H, Yaqub S and Tasken K: Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal 14: 1-9, 2002. (Pubitemid 34020823)
12. Blomhoff HK, Blomhoff R, Stokke T, deLange DC, Brevik K, Smeland EB, Funderud S and Godal T: cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1. J Cell Physiol 137: 583-587, 1988. (Pubitemid 19006747)
13. Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjoro T, Pfeifer-Ohlsson S, Watt R, Funderud S and Godal T: Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J Cell Physiol 131: 426-433, 1987. (Pubitemid 17113058)
14. Naderi S, Gutzkow KB, Christoffersen J, Smeland EB and Blomhoff HK: cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. Eur J Immunol 30: 1757-1768, 2000. (Pubitemid 30342820)
15. Naderi S, Wang JY, Chen TT, Gutzkow KB and Blomhoff HK: cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol Biol Cell 16: 1527-1542, 2005. (Pubitemid 40349585)
16. Naderi EH, Findley HW, Ruud E, Blomhoff HK and Naderi S: Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood 114: 608-618, 2009.
17. Naderi EH, Jochemsen AG, Blomhoff HK and Naderi S: Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2. Neoplasia 13: 653-663, 2011.
18. Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL and Greaves MF: Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 267: 841-843, 1977. (Pubitemid 8110160)
19. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
20. Cai R, Kwon P, Yan-Neale Y, Sambuccetti L, Fischer D and Cohen D: Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. Biochem Biophys Res Commun 283: 445-453, 2001. (Pubitemid 32924712)
21. Du M, Perry RL, Nowacki NB, Gordon JW, Salma J, Zhao J, Aziz A, Chan J, Siu KW and McDermott JC: Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol 28: 2952-2970, 2008. (Pubitemid 351556528)
22. Gerhart-Hines Z, Dominy JE Jr, Blattler SM, Jedrychowski MP, Banks AS, Lim JH, Chim H, Gygi SP and Puigserver P: The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol Cell 44: 851-863, 2011.
23. Ha CH, Kim JY, Zhao J, Wang W, Jhun BS, Wong C and Jin ZG: PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 107: 15467-15472, 2010.
24. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L and Gu W: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148, 2001. (Pubitemid 33035941)
25. Wang X, Taplick J, Geva N and Oren M: Inhibition of p53 degradation by Mdm2 acetylation. FEBS Lett 561: 195-201, 2004. (Pubitemid 38317321)
26. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J and Gu W: Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416: 648-653, 2002. (Pubitemid 34406767)
27. Batty N, Malouf GG and Issa JP: Histone deacetylase inhibitors as anti-neoplastic agents. Cancer Lett 280: 192-200, 2009.
28. Khan O and La Thangue NB: HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol 90: 85-94, 2012.